Firm Record
Gland Pharma Limited
6 findings from 2 inspection documents published by regulators. Each row below says what its date means.
US FDA · 2024-09-17 ~ 2026-10-20
Areas cited
Published inspection documents
21 CFR sections cited in FDA inspections
Citations from 2 FDA inspections (2023-07-14~2024-07-25) of facilities listed under this company name in FDA's inspection citation data.
| As written by FDA | Inspection | Latest inspection | |
|---|---|---|---|
| 21 CFR 211.180(b) | Record maintenance 1 year (except exempt OTC) | 1 | 2024-07-25 |
| 21 CFR 211.194(a) | Complete test data included in records | 1 | 2023-07-14 |
| 21 CFR 211.22(d) | Procedures not in writing, fully followed | 1 | 2024-07-25 |
1 site: Gland Pharma Limited (Hyderabad, India) · 2 inspections
Source: FDA Data Dashboard - Inspections Citations, as of 2026-11-08. Only inspections with at least one citation are included, and a section cited more than once in one inspection counts once. Only facilities whose name and legal form match this page's documents, and that are listed in a single country, are included.
Other companies with similar findings
Other companies with findings worded closely to this company's. Only documents of the same type are compared.
A record as of publication. Check the agency's own announcements for any later corrective action.
What is included. As collected on 2026-11-15: only documents with a detail page (3 or more findings). See the firm lookup for everything.